Download PDF
Thromb Haemost 1988; 59(03): 480-484
DOI: 10.1055/s-0038-1647519
Original Article
Schattauer GmbH Stuttgart

Tissue Plasminogen Activator is Endocytosed by Mannose and Galactose Receptors of Rat Liver Cells

Bård Smedsrød
1   The Department of Medical and Physiological Chemistry, University of Uppsala, Sweden
,
Monica Einarsson
2   The Research Department Biochemistry, KabiVitrum AB, Stockholm, Sweden
,
Håkan Pertoft
1   The Department of Medical and Physiological Chemistry, University of Uppsala, Sweden
› Author Affiliations
Further Information

Publication History

Received 17 July 1987

Accepted after revision 19 February 1988

Publication Date:
29 June 2018 (online)

Also available at
  PDF Download Permissions and Reprints

Summary

Experiments were carried out to charact erize the specificity of uptake of tPA in rat liver cells. Endocytosis in liver endothelial cells of the native carbohydrate variants of tissue plasminogen activator (tPA), and tPA inactivated by diisopropyl fluorophosphate was found to be competitive, suggesting that the determinant being recognized by these cells is different from the active site. Fibronectin and urokinase, which show partial homology with tPA, did not compete with tPA for uptake in liver endothelial cells. Hyaluronic acid, collagen, or IgG, which are endocytosed by specific receptors in liver endothelial cells, did not interfere with the uptake.

Reduced endocytosis by liver endothelial cells was observed with tPA modified in the carbohydrate side chains, suggesting that these structures are important for uptake. Ovalbumin, mannan, mannose, fructose, and EDTA, but not galactose, effectively inhibited uptake in liver endothelial cells of both native and diisopropyl fluorophosphate-inhibited tPA, but had very little effect on the uptake of tPA modified in the carbohydrate side chains.

Endocytosis of native tPA by parenchymal cells could be inhibited by galactose, ovalbumin, and EDTA, but not by mannose.

These results suggest that endocytosis of tPA by liver endothelial cells and parenchymal cells is mediated by the mannose and galactose receptors, respectively.

Keywords

Tissue plasminogen activator - Mannose receptor - Galactose receptor - Clearance - Liver cells
 

  • References

  • 1 Wallén P. In: Thrombosis and Urokinase. Paoletti R, Sherry S. Academic Press; New York: 1977: 91-102
  • 2 Hoylaerts M, Rijken DC, Linjen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257: 2912-2919
    PubMedSearch in Google Scholar
  • 3 Lazlo B, Varadi A, Lazlo P. Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator. FEBS Lett 1983; 163: 37-41
    CrossrefPubMedSearch in Google Scholar
  • 4 Nilsson T, Wallén P, Mellbring G. In vivo metabolism of human tissue-type plasminogen activator. Scand J Haematol 1984; 33: 49-53
    PubMedSearch in Google Scholar
  • 5 Einarsson M, Smedsrød B, Pertoft H. Uptake and degradation of tissue type plasminogen activator in rat liver. Thromb Haemostas 1988; 59: 474-479
    PubMedSearch in Google Scholar
  • 6 Pohl G, Kenne L, Nilsson B, Einarsson M. Isolation and characterization of three different carbohydrate chains from melanoma tissue plasminogen activator. Eur J Biochem 1987; 170: 69-75
    CrossrefPubMedSearch in Google Scholar
  • 7 Pohl G, Einarsson M, Nilsson B, Svensson S. The size heterogeneity in melanoma tissue plasminogen activator is caused by carbohydrate differences. Thromb Haemostas 1985; 54: 163 (Abstr)
    PubMedSearch in Google Scholar
  • 8 Lindahl U, Cifonelli JA, Lindahl B, Rodén L. The role of serine in the linkage of heparin to protein. J Biol Chem 1965; 240: 2817-2820
    PubMedSearch in Google Scholar
  • 9 Vuento M, Vaheri A. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J 1979; 18: 331-337
    CrossrefPubMedSearch in Google Scholar
  • 10 Åstedt B, Holmberg L, Wagner G, Richter P, Ploug J. Purification of urokinase by a β-naphthamidine affinity column. Thromb Haemostas 1979; 42: 924-928
    PubMedSearch in Google Scholar
  • 11 Einarsson M, Brandt J, Kaplan L. Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies. Biochim Biophys Acta 1985; 830: 1-10
    CrossrefPubMedSearch in Google Scholar
  • 12 Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3α,6α-diphenylgly-couril. Biochem Biophys Res Commun 1978; 80: 849-857
    CrossrefPubMedSearch in Google Scholar
  • 13 Smedsrød B, Pertoft H. Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence. J Leukocyte Biol 1985; 38: 213-230
    CrossrefPubMedSearch in Google Scholar
  • 14 Smedsrød B, Pertoft H, Eggertsen G, Sundström Ch. Functional and morphological characterization of pure Kupffer cells (KC) and liver endothelial cells (LEC) prepared by means of density separation in Percoll, and selective substrate adherence. Cell Tiss Res 1985; 241: 739-749
    PubMedSearch in Google Scholar
  • 15 Häggroth L, Mattsson Ch, Felding P, Nilsson IM. Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women. Thromb Res 1986; 42: 585-594
    CrossrefPubMedSearch in Google Scholar
  • 16 Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem 1982; 51: 531-554
    CrossrefPubMedSearch in Google Scholar
  • 17 Smedsrød B, Johansson S, Pertoft H. Studies in vivo and in vitro on the uptake and degradation of soluble collagen α1(I) chains in rat liver endothelial and Kupffer cells. Biochem J 1985; 228: 415-424
    CrossrefPubMedSearch in Google Scholar
  • 18 Smedsrød B, Pertoft H, Eriksson S, Fraser JR E, Laurent TC. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984; 223: 617-626
    CrossrefPubMedSearch in Google Scholar
  • 19 Rijken DC, Emeis JJ. Clearance of the heavy and light polypeptide chains of human tissue-type plasminogen activator in rats. Biochem J 1986; 238: 643-646
    CrossrefPubMedSearch in Google Scholar
  • 20 Fuchs HE, Berger Jr H, Pizzo SV. Catabolism of human tissue plasminogen activator in mice. Blood 1985; 65: 539-544
    PubMedSearch in Google Scholar
  • 21 Hubbard AL, Wilson G, Stukenbrok H. An electron microscope-autoradiographic study of the carbohydrate recognition system in rat liver. I. Distribution of 125I-ligands among the liver cell types. J Cell Biol 1979; 83: 47-64
    CrossrefPubMedSearch in Google Scholar
  • 22 Summerfield JA, Vergalla J, Jones EA. Modulation of a glycoprotein recognition system on rat hepatic endothelial cells by glucose and diabetes mellitus. J Clin Invest 1982; 69: 1337-1347
    CrossrefPubMedSearch in Google Scholar
  • 23 Hildenbrandt GR, Aronson Jr NN. Endocytosis of bovine lactoperoxidase by two carbohydrate-specific receptors in rat liver. Arch Biochem Biophys 1985; 237: 1-10
    CrossrefPubMedSearch in Google Scholar
  • 24 Hughes RC. Glycoproteins. Chapman and Hall; London: 1983: 17
    Search in Google Scholar
  • 25 Emeis JJ, van den Hoogen CM, Jense D. Hepatic clearance of tissue-type plasminogen activator in rats. Thromb Haemostas 1985; 54: 661-664
    PubMedSearch in Google Scholar
  • 26 Bakhit C, Lewis D, Billings D, Malfroy B. Cellular catabolism of recombinant tissue-type plasminogen activator. J Biol Chem 1987; 262: 8716-8720
    PubMedSearch in Google Scholar
  • 27 Lau D, Kuzma G, Wei C-M, Livingston DJ, Hsiung N. A modified human tissue plasminogen activator with extended half-life in vivo. Bio/Technology 1987; 55: 953-958
    PubMedSearch in Google Scholar